Operating Lease, Right-of-Use Asset in USD of Iterum Therapeutics plc from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Iterum Therapeutics plc quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Iterum Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Iterum Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $0 -$264K -100% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $0 -$378K -100% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $19K -$445K -95.9% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $65K -$484K -88.2% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $264K -$366K -58.1% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $378K -$1.22M -76.3% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $464K -$1.22M -72.4% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $549K -$1.22M -69% 31 Dec 2023 10-K 07 Feb 2025
Q3 2023 $630K -$1.23M -66.1% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $1.6M -$618K -27.9% 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 $1.68M -$1.98M -54% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $1.77M -$1.97M -52.7% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $1.86M -$2.04M -52.3% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $2.21M -$1.87M -45.8% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $3.66M -$1.59M -30.3% 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $3.74M -$1.52M -28.9% 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 $3.89M -$2.84M -42.2% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $4.08M -$2.81M -40.8% 30 Jun 2021 10-Q 13 Aug 2021
Q1 2021 $5.25M -$1.77M -25.2% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $5.26M -$1.88M -26.4% 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 $6.74M -$529K -7.28% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 $6.89M -$494K -6.69% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $7.02M -$485K -6.46% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 $7.14M 31 Dec 2019 10-K 12 Mar 2021
Q3 2019 $7.27M 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $7.39M 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $7.5M 31 Mar 2019 10-Q 14 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.